Read the latest positive news, breakthroughs, and inspiring stories about pediatric medicine, curated daily by BrightWire.
A Minnesota boy with Duchenne muscular dystrophy is showing remarkable improvement after receiving an experimental therapy that helps his muscles produce a vital protein. While the treatment currently reaches only a fraction of patients, it represents a breakthrough in targeting this fatal disease.
Six-year-old Tiara is finally getting to be a kid, playing and going to school without the pain crises and hospital stays that once defined her life. She and other young patients in New Jersey just marked a milestone many thought impossible: more than a year free from sickle cell disease after receiving cutting-edge treatments.
Children's bodies respond differently to medicine than adults, sometimes fatally. Now, thanks to one researcher's determination, the world's first comprehensive map of healthy pediatric cells is changing that.
A simple liquid painted on cavities stops tooth decay in young children without drilling, shots, or sedation. A major U.S. study of 830 kids shows this could transform how we treat the most common childhood disease.
Children as young as two can now receive a groundbreaking gene therapy that offers a potential cure for sickle cell disease. The FDA's approval of Casgevy marks a historic expansion that could prevent irreversible damage before it starts.
Blood Cancer United purchased a discontinued experimental cancer drug to keep it available for children with rare leukemia. The organization will distribute Luvelta free to about 20 young patients each year while supplies last.
Al Qassimi Women's and Children's Hospital in Sharjah just completed the UAE's first series of robotic surgeries on kids, bringing cutting-edge precision medicine to pediatric care. The successful procedures mean safer, less invasive treatment for young patients across the Emirates.
A one-week-old baby received groundbreaking gene therapy for a fatal disease just days after FDA approval, transforming what doctors once called a "death sentence" into a life full of possibility. Today, 10-month-old Samuel is crawling, smiling, and showing no signs of the disease that would have confined him to a wheelchair.
A groundbreaking treatment for brain injuries in newborns just secured $40 million to complete clinical trials, offering hope where no approved drugs currently exist. The therapy targets HIE, a condition that affects 1.2 million babies worldwide each year.
A Japanese pharmaceutical company is helping treat a devastating parasitic disease in African children who were previously too young for medication. The new medicine tackles schistosomiasis, a water-borne illness that stunts growth in kids across sub-Saharan Africa.
Babies born without vital gut nerves may soon receive a permanent cure instead of repeated surgeries. UK researchers created lab-grown stem cells that restore digestive function in just six days.
The FDA just approved Denali Therapeutics' new medicine for Hunter syndrome, bringing fresh hope to families affected by this rare genetic disease. The approval comes as a welcome surprise after the agency recently toughened its standards for rare disease treatments.